What is Tilray Brands, Inc. (TLRY) stock price today?

Tilray Brands, Inc. (TLRY) is currently trading at $3.48, down 3.02% today.

What is TLRY P/E ratio?

Tilray Brands, Inc.'s P/E ratio is -2.74. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is TLRY return on equity (ROE)?

Tilray Brands, Inc.'s return on equity (ROE) is -7.95%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is Tilray Brands, Inc.'s market cap?

Tilray Brands, Inc. has a market capitalization of $389.34M.

NASDAQ · Drug Manufacturers - Specialty & Generic

Tilray Brands, Inc. (TLRY) Stock

$3.48 -3.02% NASDAQ: TLRY Healthcare

Valuation

Metric	Value
Price	$3.48
Market Cap	$389.34M
P/E Ratio	-2.74
P/B Ratio	0.25
P/S Ratio	0.35
EPS (TTM)	$0.27
52-Week High	$23.20
52-Week Low	$3.48
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-7.95%
ROA	-6.40%
ROCE	-3.04%
Gross Margin	27.67%
Operating Margin	-1.72%
Net Margin	-12.90%
Debt/Equity	0.25
Current Ratio	2.45

Annual Financials (USD)

Metric	2022	2023	2024	2025	2026
Revenue	$628.0M	$845.0M	$1.1B	$1.1B	$915.0M
Operating Profit	$-233.0M	$-1.8B	$-238.0M	$-3.1B	$-63.0M
Net Profit	$-477.0M	$-2.0B	$-334.0M	$-3.0B	$-123.0M
EPS	$-9.94	$-31.70	$-4.50	$-33.80	$-1.09
Op Margin	-37.1%	-218.4%	-22.1%	-277.9%	-6.9%

Balance Sheet (USD)

Metric	2022	2023	2024	2025	2026
Total Assets	$6.9B	$5.9B	$5.9B	$2.9B	$2.3B
Total Liabilities	$1.3B	$1.4B	$1.2B	$860.0M	$733.0M
Cash	$524.0M	$278.0M	$311.0M	$304.0M	$226.0M
Borrowings	$786.0M	$795.0M	$528.0M	$451.0M	$398.0M

Latest News

PSKY, ORCL, TLRY Stocks Hit 52-Week Lows Today: What's Driving The Selloff? Stocktwits · Jul 21, 2026 Tilray Brands, Inc. (TLRY) Declines More Than Market: Some Information for Investors Zacks · Jul 20, 2026 Should You Buy Tilray Brands Stock Before July 28? Motley Fool · Jul 20, 2026 Tilray Brands' BrewDog Kicks Off 1 Million Pound Bar Tab in The UK MT Newswires · Jul 17, 2026 BrewDog and Tilray Brands Unlock £1 Million Bar Tab for Football Fans Across England, Scotland and Ireland GlobeNewswire · Jul 17, 2026

Cash Flow (USD)

Metric	2022	2023	2024	2025	2026
Operating Cash Flow	$-223.0M	$11.0M	$-42.0M	$-130.0M	$-69.0M
Investing Cash Flow	$-70.0M	$-412.0M	$135.0M	$-109.0M	$-89.0M
Financing Cash Flow	$-19.0M	$-3.0M	$-4.0M	$-6.0M	$0
Net Cash Flow	$-91.0M	$-282.0M	$30.0M	$-9.0M	$8.0M
Free Cash Flow	$-266.0M	$-17.0M	$-82.0M	$-175.0M	$-102.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	-0.02
EV / EBITDA	35.87
FCF Yield	-27.88%
Quick Ratio	1.37
Interest Coverage	-1.99
Return 1Y	-46.08%
Return 3Y	-76.39%
Return 5Y	-96.96%

Ownership

Insiders Held0.72%

Institutions Held9.35%

Institutions Float Held9.42%

Institutional Holder	Shares	Report Date
Tidal Investments LLC	2,563,689	2026-03-31
UBS Group AG	653,001	2026-03-31
Morgan Stanley	641,025	2026-03-31
Susquehanna International Group, LLP	542,232	2026-03-31
Mirae Asset Global ETFs Holdings Ltd.	486,820	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AAPLApple Inc.	$333.65	-1.99%	38.93	$4.90T	0.32%
MSFTMicrosoft Corporation	$533.07	+2.00%	28.68	$3.96T	0.76%
GOOGLAlphabet Inc.	$351.89	+1.03%	16.94	$4.26T	0.26%
AMZNAmazon.com, Inc.	$260.45	+2.51%	19.82	$2.80T	0.00%
METAMeta Platforms, Inc.	$722.47	+0.22%	27.93	$1.84T	0.28%

About Tilray Brands, Inc.

Tilray Brands, Inc. is led by CEO Irwin David Simon, employs 2,650 people, headquartered in CA, publicly traded since 2018.

Tilray Brands, Inc. (TLRY) stock trades at $3.48 with a market capitalization of $389.34M. The stock is valued at a price-to-earnings (P/E) ratio of -2.74, price-to-book of 0.25, price-to-sales of 0.35. Over the past 52 weeks the stock has ranged between $3.48 and $23.20, and currently trades 85.0% below its 52-week high.

On profitability, Tilray Brands, Inc. generates a return on equity (ROE) of -7.95%, return on capital employed of -3.04%, an operating margin of -1.72%, a net profit margin of -12.90%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1165.96 -0.31% JNJ Johnson & Johnson $258.30 +0.71% ABBV AbbVie Inc. $274.04 +0.59% MRK Merck & Company, Inc. Common Stock (new) $144.72 +1.64% UNH UnitedHealth Group Incorporated Common Stock (DE) $374.26 +0.89% NVS Novartis AG $143.67 +0.39% AZN AstraZeneca PLC $159.80 +0.64% TMO Thermo Fisher Scientific Inc $654.06 +0.32% AMGN Amgen Inc. $409.33 +0.46% GILD Gilead Sciences, Inc. $148.70 +1.09% ABT Abbott Laboratories $99.35 +0.87% NVO Novo Nordisk A/S $38.18 -0.21%

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides